Fort Washington Investment Advisors Inc. OH Increases Holdings in Cardinal Health, Inc. (NYSE:CAH)

Fort Washington Investment Advisors Inc. OH grew its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 10.5% in the 4th quarter, HoldingsChannel reports. The firm owned 11,883 shares of the company’s stock after acquiring an additional 1,132 shares during the quarter. Fort Washington Investment Advisors Inc. OH’s holdings in Cardinal Health were worth $1,405,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. Atomi Financial Group Inc. purchased a new stake in Cardinal Health in the 4th quarter worth about $239,000. Transform Wealth LLC purchased a new stake in Cardinal Health in the 4th quarter worth about $1,197,000. Clear Harbor Asset Management LLC purchased a new stake in Cardinal Health in the 4th quarter worth about $442,000. Ballentine Partners LLC boosted its stake in Cardinal Health by 14.7% in the 4th quarter. Ballentine Partners LLC now owns 3,686 shares of the company’s stock worth $436,000 after purchasing an additional 471 shares during the period. Finally, MassMutual Private Wealth & Trust FSB boosted its stake in Cardinal Health by 32.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,438 shares of the company’s stock worth $170,000 after purchasing an additional 353 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Price Performance

NYSE:CAH opened at $129.38 on Friday. The business has a 50 day moving average of $121.15 and a 200 day moving average of $112.70. The company has a market capitalization of $31.31 billion, a price-to-earnings ratio of 25.17, a PEG ratio of 1.55 and a beta of 0.63. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $129.68.

Cardinal Health (NYSE:CAH) last released its earnings results on Friday, November 1st. The company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The company had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. Cardinal Health’s quarterly revenue was down 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.73 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were paid a $0.5056 dividend. The ex-dividend date of this dividend was Thursday, January 2nd. This represents a $2.02 dividend on an annualized basis and a yield of 1.56%. Cardinal Health’s dividend payout ratio (DPR) is currently 39.30%.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. Mizuho assumed coverage on Cardinal Health in a research note on Wednesday, December 4th. They issued an “outperform” rating and a $139.00 target price for the company. Bank of America upgraded Cardinal Health from a “neutral” rating to a “buy” rating and raised their target price for the stock from $132.00 to $145.00 in a research note on Monday, January 6th. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target for the company in a research report on Tuesday, January 7th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Cardinal Health from $119.00 to $124.00 and gave the company a “hold” rating in a research report on Monday, November 4th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $133.29.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.